跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,678 条关于
“A2A Pharmaceuticals”
全部
11,678
临床试验
2,573
药物
2,141
机构
2,068
资讯
4,896
6个月前
Vimgreen's A2A Receptor Antagonist VG081821 Receives First Global IND Approval for NASH Treatment
去年
iTeos Therapeutics Presents Inupadenant Data at ESMO IO Congress, Prioritizes Other Programs
6个月前
Roquefort Therapeutics Acquires TACC3 Inhibitor AO-252 in £31.9M Deal, Rebrands as Coiled Therapeutics
2年前
Vimgreen Completes Enrollment in Phase 2 Trial of VG081821AC for Parkinson's Disease
11年前
AstraZeneca Expands Immuno-Oncology Portfolio with Three Strategic Partnerships
11个月前
Corvus Pharmaceuticals Reports Promising Interim Data for Ciforadenant Triple Therapy in Metastatic Renal Cell Cancer
去年
Ciforadenant Shows Promise in Overcoming Immunotherapy Resistance in Prostate Cancer
去年
Marvel Biosciences Receives $300,000 Grant to Advance Alzheimer's Drug MB204
去年
iTeos Deprioritizes Inupadenant for NSCLC Treatment After Mid-Stage Data
去年
Marvel Biosciences Raises $1.02 Million to Advance Novel Neurological Drug MB-204
第 1 页,共 490 页
上一页
下一页